Clinical and Molecular Inflammatory Response in Sjögren Syndrome-Associated Dry Eye Patients under Desiccating Stress

American Journal of Ophthalmology

Volumn 161, Issue , 2016, Pages 133-141.e2

  López Miguel, Alberto ^a,b   Tesón, Marisa ^a   Martín Montañez, Vicente ^a   Enríquez De Salamanca, Amalia ^a,c   Stern, Michael E ^d   González García, María J ^a,c   Calonge, Margarita ^a,c  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b Vision I+D SL   (Spain)

^c UNIVERSITY OF VALLADOLID   (Spain)

^d ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; VASCULOTROPIN; EYE PROTEIN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; TEAR PROTEINS;

ADULT; AGED; AIRFLOW; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVAL HYPEREMIA; CONJUNCTIVAL LISSAMINE GREEN STAINING; CORNEAL FLUORESCEIN STAINING; DRY EYE; EYE INFLAMMATION; FEMALE; FLUORESCEIN TEAR BREAK UP TIME; HUMAN; HUMIDITY; LACRIMAL FLUID LEVEL; LACRIMAL GLAND FUNCTION; PHENOL RED THREAD TEST; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHIRMER TEST; SIMULATION; SJOEGREN SYNDROME; STAINING; TEAR OSMOLARITY; VISUAL SYSTEM EXAMINATION; CHEMISTRY; CROSSOVER PROCEDURE; FLUOROPHOTOMETRY; LACRIMAL FLUID; LACRIMAL GLAND DISEASE; METABOLISM; MICROCLIMATE; MIDDLE AGED; OSMOLARITY; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PROCEDURES;

ADULT; AGED; CROSS-OVER STUDIES; DRY EYE SYNDROMES; ENVIRONMENT, CONTROLLED; EYE PROTEINS; FEMALE; FLUOROPHOTOMETRY; HUMANS; HUMIDITY; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-6; INTERLEUKIN-8; LACRIMAL APPARATUS DISEASES; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OSMOLAR CONCENTRATION; PILOT PROJECTS; PROSPECTIVE STUDIES; SJOGREN'S SYNDROME; STAINING AND LABELING; STRESS, PHYSIOLOGICAL; TEARS;

EID: 84959327759     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2015.09.039     Document Type: Article

References (49)

1. M.E. Stern, R.W. Beuerman, R.I. Fox, J. Gao, A.K. Mircheff, and S.C. Pflugfelder The pathology of dry eye: the interaction between the ocular surface and lacrimal glands Cornea 17 6 1998 584 589
2. A.M. Lemp, C. Baudouin, J. Baum, and et al. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) Ocul Surf 5 2 2007 75 92
3. D.A. Schaumberg, R. Dana, J.E. Buring, and D.A. Sullivan Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies Arch Ophthalmol 127 6 2009 763 768
4. D.A. Schaumberg, D.A. Sullivan, J.E. Buring, and M.R. Dana Prevalence of dry eye syndrome among US women Am J Ophthalmol 136 2 2003 318 326
5. A. Galor, W. Feuer, D.J. Lee, and et al. Prevalence and risk factors of dry eye syndrome in a United States Veterans Affairs population Am J Ophthalmol 152 3 2011 377 384
6. R. Patel, and A. Shahane The epidemiology of Sjögren's syndrome Clin Epidemiol 6 2014 247 255
7. M. García-Carrasco, M. Ramos-Casals, J. Rosas, and et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients Medicine (Baltimore) 81 4 2002 270 280
8. H.S. Brightman, D.K. Milton, D. Wypij, H.A. Burge, and J.D. Spengler Evaluating building-related symptoms using the US EPA BASE study results Indoor Air 18 4 2008 335 345
9. P. Wolkoff Ocular discomfort by environmental and personal risk factors altering the precorneal tear film Toxicol Lett 199 3 2010 203 212
10. M. Uchino, D.A. Schaumberg, M. Dogru, and et al. Prevalence of dry eye disease among Japanese visual display terminal users Ophthalmology 115 11 2008 1982 1988
11. J.D. Sheppard, G.L. Torkildsen, J.D. Lonsdale, and et al. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study Ophthalmology 121 2 2014 475 483
12. L.C. Madden, A. Tomlinson, and P.A. Simmons Effect of humidity variations in a controlled environment chamber on tear evaporation after dry eye therapy Eye Contact Lens 39 2 2013 169 174
13. M. Tesón, M.J. González-García, A. López-Miguel, and et al. Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease Invest Ophthalmol Vis Sci 54 3 2013 2093 2099
14. A. Alex, A. Edwards, J.D. Hays, and et al. Factors predicting the ocular surface response to desiccating environmental stress Invest Ophthalmol Vis Sci 54 5 2013 3325 3332
15. Q.L. Moore, C.S. De Paiva, and S.C. Pflugfelder Effects of dry eye therapies on environmentally induced ocular surface disease Am J Ophthalmol 160 1 2015 135 142
16. S.C. Pflugfelder, D. Jones, Z. Ji, A. Afonso, and D. Monroy Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca Curr Eye Res 19 3 1999 201 211
17. S.Y. Lee, S.J. Han, S.M. Nam, and et al. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients Am J Ophthalmol 156 2 2013 247 253
18. K.C. Yoon, I.Y. Jeong, Y.G. Park, and S.Y. Yang Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome Cornea 26 4 2007 431 437
19. A. Solomon, D. Dursun, Z. Liu, Y. Xie, A. Macri, and S.C. Pflugfelder Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry eye disease Invest Ophthalmol Vis Sci 42 10 2001 2283 2292
20. D.A. Sullivan, K.M. Hammitt, D.A. Schaumberg, and et al. Report of the TFOS/ARVO Symposium on global treatments for dry eye disease: an unmet need Ocul Surf 10 2 2012 108 116
21. S.C. Pflugfelder, G. Geerling, S. Kinoshita, and et al. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007) Ocul Surf 5 2 2007 163 178
22. R.M. Schiffman, M.D. Christianson, G. Jacobsen, J.D. Hirsch, and B.L. Reis Reliability and validity of the Ocular Surface Disease Index Arch Ophthalmol 118 5 2000 615 621
23. C. Baudouin, P. Aragona, G. Van Setten, and et al. Diagnosing the severity of dry eye: a clear and practical algorithm Br J Ophthalmol 98 9 2014 1168 1176
24. C. Vitali, S. Bombardieri, R. Jonsson, and et al. Classification criteria for Sjogren's Syndrome: a revised version of the European criteria proposed by the American-European Consensus Group Ann Rheum Dis 61 6 2002 554 558
25. A. López-Miguel, M. Tesón, V. Martín-Montañez, and et al. Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions Am J Ophthalmol 157 4 2014 788 798
26. N. Efron Grading scales for contact lens complications Ophthalmic Physiol Opt 18 2 1998 182 186
27. A.J. Bron The Doyne Lecture. Reflections on the tears Eye 11 5 1997 583 602
28. S.C. Pflugfelder, R.W. Beurerman, and M.E. Stern Dry Eye and Ocular Surface Disorders 2004 Marcel Dekker New York
29. J.F. Huang, R. Yafawi, M. Zhang, and et al. Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease Ophthalmology 119 7 2012 43 50
30. M.J. Doughty Consideration of three types of spontaneous eyeblink activity in normal humans: during reading and video display terminal use, in primary gaze, and while in conversation Optom Vis Sci 78 10 2001 712 725
31. A.A. Abusharha, and E.I. Pearce The effect of low humidity on the human tear film Cornea 32 4 2013 429 434
32. C. Baudouin, P. Aragona, E.M. Messmer, and et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting Ocul Surf 11 4 2013 246 258
33. A.J. Bron, M.B. Abelson, G. Ousler, and et al. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007) Ocul Surf 5 2 2007 108 152
34. K.K. Nichols, G.L. Mitchell, and K. Zadnik The repeatability of clinical measurements of dry eye Cornea 23 3 2004 272 285
35. B.D. Sullivan, L.A. Crews, B. Sönmez, and et al. Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management Cornea 31 9 2012 1000 1008
36. J.F. Huang, Y. Zhang, K.D. Rittenhouse, E.H. Pickering, and M.T. McDowell Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease Invest Ophthalmol Vis Sci 53 8 2012 4556 4564
37. A. Enriquez-de-Salamanca, E. Castellanos, M.E. Stern, and et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease Mol Vis 16 2010 862 873
38. F. Amparo, M.H. Dastjerdi, A. Okanobo, and et al. Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial JAMA Ophthalmol 131 6 2013 715 723
39. H. Lam, L. Bleiden, C.S. de Paiva, W. Farley, M.E. Stern, and S.C. Pflugfelder Tear cytokine profiles in dysfunctional tear syndrome Am J Ophthalmol 147 2 2009 198 205
40. K.S. Na, J.W. Mok, J.Y. Kim, C.R. Rho, and C.K. Joo Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease Invest Ophthalmol Vis Sci 53 9 2012 5443 5450
41. A. Higuchi, T. Kawakita, and K. Tsubota IL-6 induction in desiccated corneal epithelium in vitro and in vivo Mol Vis 17 2011 2400 2406
42. M.J. Benito, M.J. González-García, M. Tesón, and et al. Intra- and inter-day variation of cytokines and chemokines in tears of healthy subjects Exp Eye Res 120 2014 43 49
43. M.L. Massingale, X. Li, M. Vallabhajosyula, D. Chen, Y. Wei, and P.A. Asbell Analysis of inflammatory cytokines in the tears of dry eye patients Cornea 28 9 2009 1023 1027
44. S. Chotikavanich, C.S. De Paiva, Q. Li de, and et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome Invest Ophthalmol Vis Sci 50 7 2009 3203 3209
45. R.M. Corrales, M.E. Stern, C.S. De Paiva, J. Welch, D.Q. Li, and S.C. Pflugfelder Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium Invest Ophthalmol Vis Sci 47 8 2006 3293 3302
46. R. Sambursky, W.F. Davitt 3rd, R. Latkany, and et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye JAMA Ophthalmol 131 1 2013 24 28
47. M. Mori, E. De Lorenzo, E. Torre, and et al. A highly soluble matrix metalloproteinase-9 inhibitor for potential treatment of dry eye syndrome Basic Clin Pharmacol Toxicol 111 5 2012 289 295
48. Y. Ding, Q. Fu, Z. Tian, M. Li, and N. Zhu Influence of indoor design air parameters on energy consumption of heating and air conditioning Energy and Buildings 56 2013 78 84
49. G.N. Foulks Challenges and pitfalls in clinical trials of treatments for dry eye Ocul Surf 1 1 2003 20 30